Cargando…

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma

Pathogenic viruses have evolved to manipulate the host cell utilising a variety of strategies including expression of viral proteins to hijack or mimic the activity of cellular functions. DNA tumour viruses often establish latent infection in which no new virions are produced, characterized by the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vrzalikova, Katerina, Sunmonu, Taofik, Reynolds, Gary, Murray, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161176/ https://www.ncbi.nlm.nih.gov/pubmed/29954084 http://dx.doi.org/10.3390/pathogens7030059

Ejemplares similares

Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma
por: Ross, Aisling M., et al.
Publicado: (2023)

Molecular Characterisation of Epstein–Barr Virus in Classical Hodgkin Lymphoma
por: Begić, Valerija, et al.
Publicado: (2022)

Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein–Barr Virus in Classical Hodgkin Lymphoma
por: Santisteban-Espejo, Antonio, et al.
Publicado: (2021)

Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma
por: Sarwari, Nawid M., et al.
Publicado: (2016)

Epstein-Barr virus and the origin of Hodgkin lymphoma
por: Vockerodt, Martina, et al.
Publicado: (2014)

Epstein Barr Virus-Associated Hodgkin Lymphoma
por: Carbone, Antonino, et al.
Publicado: (2018)

Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China
por: Huang, Xin, et al.
Publicado: (2011)

Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL
por: Nohtani, Mahdi, et al.
Publicado: (2022)

The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein–Barr virus presence and location within the tumor
por: Wu, R, et al.
Publicado: (2016)

Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas
por: Vrzalikova, Katerina, et al.
Publicado: (2012)

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021)

Evidence that Amphotericin B Mediates Reactivation of Latent Epstein-Barr Virus in Hodgkin's Lymphoma Allowing Cytotoxicity by Acyclovir
por: Kast, Richard E.
Publicado: (2006)

Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells
por: Pavlovic, Antonia, et al.
Publicado: (2016)

Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma
por: Nagel, Stefan, et al.
Publicado: (2022)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Assessment of the prognostic impact of the Epstein–Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease
por: Glavina-Durdov, M, et al.
Publicado: (2001)

Arginine Methyltransferases Are Regulated by Epstein-Barr Virus in B Cells and Are Differentially Expressed in Hodgkin’s Lymphoma
por: Leonard, Sarah, et al.
Publicado: (2012)

Epstein‐Barr virus latent membrane protein‐1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy
por: Lin, Hui‐Chen, et al.
Publicado: (2021)

Hemophagocytic Lymphohistiocytosis in a Patient with Hodgkin Lymphoma, HIV, and Epstein-Barr Virus
por: Javed, Faiza, et al.
Publicado: (2023)

Plasma Epstein–Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses
por: Sinha, Mahua, et al.
Publicado: (2016)

CD20 expression is closely associated with Epstein–Barr virus infection and an inferior survival in nodular sclerosis classical Hodgkin lymphoma
por: Zhao, Xia, et al.
Publicado: (2022)

HLA-DPB1 and Epstein-Barr virus gp42 protein jointly contribute to the development of Hodgkin lymphoma
por: Li, Hongyu, et al.
Publicado: (2020)

Variable Expression of Notch1 and Pax5 in Classical Hodgkin Lymphoma and Infection with Epstein–Barr in Pediatric Patients
por: Palma-Lara, Icela, et al.
Publicado: (2020)

Epstein–Barr Virus History and Pathogenesis
por: Yu, Hui, et al.
Publicado: (2023)

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma
por: Tanyildiz, Hikmet Gulsah, et al.
Publicado: (2015)

Hemophagocytic Lymphohistiocytosis Induced by Epstein-Barr Virus Infection and Newly Diagnosed Hodgkin Lymphoma
por: Landry, Ian, et al.
Publicado: (2021)

Epstein–Barr virus mucocutaneous ulcer followed by Hodgkin lymphoma in multiple myeloma patient
por: Forster, Moriah, et al.
Publicado: (2022)

Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)
por: Bahri, Racha, et al.
Publicado: (2022)

Composite Lymphoma with Follicular Lymphoma Transformation to Clonally Related Epstein–Barr Virus (EBV) Positive Diffuse Large B-Cell Lymphoma and EBV-PositiveClassic Hodgkin Lymphoma
por: Ryder, Christopher B., et al.
Publicado: (2023)

Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023)

Epstein-Barr virus and Burkitt lymphoma
por: Rowe, Martin, et al.
Publicado: (2014)

Epstein–Barr virus-associated lymphomas
por: Shannon-Lowe, Claire, et al.
Publicado: (2017)

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
por: De Re, Valli, et al.
Publicado: (2020)

Cytolytic T lymphocytes from HLA-B8(+ )donors frequently recognize the Hodgkin's lymphoma associated latent membrane protein 2 of Epstein Barr virus
por: Tsang, Ming L, et al.
Publicado: (2011)

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004)

Blood Epstein–Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma
por: Ul-Haq, Ikram, et al.
Publicado: (2018)

The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
por: Hu, Jianyu, et al.
Publicado: (2022)

Immunotherapy for Epstein-Barr Virus-Related Lymphomas
por: Kennedy-Nasser, Alana A., et al.
Publicado: (2009)

Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease.
por: Mueller, N.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_dhs28hnsr344i91b0p36ehoco2